oppenheimer - Search News

Oppenheimer starts IBM with Outperform

Not your father’s IBM, says Oppenheimer as it starts coverage with outperform

Oppenheimer initiated coverage of International Business Machines (NYSE:IBM) with an “Outperform” rating and a $320 price target, citing the company’s transformation into a software-driven business with strong growth potential.

Business Insider · 1d

Oppenheimer starts IBM with Outperform amid pivot to software

Oppenheimer initiated coverage of IBM (IBM) with an Outperform rating and $320 price target The firm’s bullish stance is based on the view

Fintel on MSN · 14h

Oppenheimer Initiates Coverage of International Business Machines (IBM) with Outperform Recommendation

Fintel reports that on February 11, 2025, Oppenheimer initiated coverage of International Business Machines (NYSE:IBM) with a Outperform recommendation. Analyst Price Forecast Suggests 12.51% Downside As of January 28,

Seeking Alpha on MSN · 22h

IBM initiated at Outperform as software accelerates at Big Blue: Oppenheimer

IBM (NYSE:IBM) was initiated with an Outperform rating by Oppenheimer due in part to double-digit revenue growth in its software segment, driven by its Red Hat offerings. "Red Hat specifically has recently expanded its product focus with multiple partner integrations that can help drive a high-teens to 20% growth for the segment,

Oppenheimer Keeps Their Buy Rating on Gilead Sciences (GILD)

In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

3hon MSN

Oppenheimer maintains Cheesecake Factory outperform rating

Oppenheimer analysts maintained their positive stance on Cheesecake Factory (NASDAQ:CAKE) stock, reiterating an Outperform rating and a $65.00 price target. The optimism stems from a belief in the ...

Jewish Telegraphic Agency1d

The Jewish story behind ‘Oppenheimer,’ explained

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Oppenheimer Reiterates Market Perform Rating for Pliant Therapeutics (NASDAQ:PLRX)

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports ...

Oppenheimer: Solid Topline Performance And Multiple, But Comp Expense Caps Profit Growth

AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.

Cillian Murphy Learned 30,000 Words Of Dutch For One Scene In Oppenheimer – Here’s How He Did It

Cillian Murphy’s dedication to Oppenheimer went beyond acting—he learned 30,000 words of Dutch, followed a brutal diet, and ...

13don MSN

Another Oppenheimer actor is reuniting with Christopher Nolan for his next movie as filming begins next month

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Oppenheimer Cuts Regal Rexnord (NYSE:RRX) Price Target to $190.00

Regal Rexnord (NYSE:RRX – Free Report) had its price objective reduced by Oppenheimer from $210.00 to $190.00 in a research note issued to investors on Friday,Benzinga reports. Oppenheimer currently ...